Riin Reimets

Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration

Mario Plaas, Kadri Seppa, Riin Reimets et al. · Scientific Reports · 2017 · 65 citations · Full text

Life Sciences, Genetics, Neuroscience +15

GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome

Kadri Seppa, Maarja Toots, Riin Reimets et al. · Scientific Reports · 2019 · 57 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model

Kadri Seppa, Toomas Jagomäe, Kaia Grete Kukker et al. · Scientific Reports · 2021 · 34 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

Toomas Jagomäe, Kadri Seppa, Riin Reimets et al. · Cells · 2021 · 28 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Evidence for impaired function of dopaminergic system in Wfs1-deficient mice

Tanel Visnapuu, Mario Plaas, Riin Reimets et al. · Behavioural Brain Research · 2013 · 22 citations

Life Sciences, Neurobiology, Neuroscience +16